CA
LCTX icon

Crewe Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Crewe Advisors’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,016
Closed -$1.01K – 863
2024
Q2 		$1.01K Hold
1,016
– – ﹤0.01% 894
2024
Q1 		$1.5K Buy
+1,016
New +$1.5K ﹤0.01% 865